HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) IN GASTRIC CANCER (GC) (RESULTS OF THE MULTICENTER CLINICAL TRIAL)

HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) IN GASTRIC CANCER (GC) (RESULTS OF THE MULTICENTER CLINICAL TRIAL)

In this article results of the multicenter trial are displayed. Data of successful efficacy of trastuzumab treatment in HER2 positive gastric cancer patients has shown.

Bibliographic Details
Main Authors: H. C. Chung, Y-J. Bang, J. M. Xu, F. Lordick, A. Sawaki, O. Lipatov, M. Lehle, М. Pickl, J. Ruschoff, E. Van Cutsem
Format: Article
Language:English
Published: Bashkir State Medical University 2017-02-01
Series:Креативная хирургия и онкология
Subjects:
gastric cancer
chemotherapy
her2 testing
trastuzumab
Online Access:https://www.surgonco.ru/jour/article/view/185

Internet

https://www.surgonco.ru/jour/article/view/185

Similar Items